Lyra Therapeutics files for $300M mixed shelf
Lyra Therapeutics files for $300M mixed shelf
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
-
Leap Therapeutics files for $200M mixed shelf offering
SeekingAlpha
-
Allogene Therapeutics files for $500M mixed shelf
SeekingAlpha
-
Cadrenal Therapeutics files for $100M mixed shelf
SeekingAlpha
-
Oncternal Therapeutics files for mixed shelf offering
SeekingAlpha
Advertisement
More coverage
Vyne Therapeutics files for $250M mixed shelf
SeekingAlpha